254 related articles for article (PubMed ID: 16313292)
1. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening.
Shah S; Montgomery H; Smith C; Madge S; Walker P; Evans H; Johnson M; Sabin C
HIV Med; 2006 Jan; 7(1):46-52. PubMed ID: 16313292
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
3. Cervical screening: Perceptions and barriers to uptake among Somali women in Camden.
Abdullahi A; Copping J; Kessel A; Luck M; Bonell C
Public Health; 2009 Oct; 123(10):680-5. PubMed ID: 19863980
[TBL] [Abstract][Full Text] [Related]
4. Intercultural consultations: investigation of factors that deter non-English speaking women from attending their general practitioners for cervical screening.
Naish J; Brown J; Denton B
BMJ; 1994 Oct; 309(6962):1126-8. PubMed ID: 7987106
[TBL] [Abstract][Full Text] [Related]
5. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
6. Determinants and evolution of squamous intraepithelial lesions in HIV-infected women, 1991-2004.
Drogoul-Vey MP; Marimoutou C; Robaglia-Schlupp A; Beerli M; Gastaut JA; Cau P; Poizot-Martin I
AIDS Care; 2007 Sep; 19(8):1052-7. PubMed ID: 17852004
[TBL] [Abstract][Full Text] [Related]
7. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women.
Korn AP; Autry M; DeRemer PA; Tan W
Obstet Gynecol; 1994 Mar; 83(3):401-4. PubMed ID: 8127533
[TBL] [Abstract][Full Text] [Related]
9. Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.
Grewal J; Lowe M; Gerrard H; Henley R; Perkins N; Briggs S
N Z Med J; 2010 Jul; 123(1319):71-8. PubMed ID: 20717179
[TBL] [Abstract][Full Text] [Related]
10. Is a history of trauma associated with a reduced likelihood of cervical cancer screening?
Farley M; Golding JM; Minkoff JR
J Fam Pract; 2002 Oct; 51(10):827-31. PubMed ID: 12401150
[TBL] [Abstract][Full Text] [Related]
11. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.
del Carmen MG; Findley M; Muzikansky A; Roche M; Verrill CL; Horowitz N; Seiden MV
Gynecol Oncol; 2007 Jan; 104(1):70-6. PubMed ID: 16949138
[TBL] [Abstract][Full Text] [Related]
12. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
13. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
14. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
15. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
16. Women's attitudes to HIV screening in pregnancy in an area of low prevalence.
Jha S; Gee H; Coomarasamy A
BJOG; 2003 Feb; 110(2):145-8. PubMed ID: 12618158
[TBL] [Abstract][Full Text] [Related]
17. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization.
Tacken MA; Braspenning JC; Hermens RP; Spreeuwenberg PM; van den Hoogen HJ; de Bakker DH; Groenewegen PP; Grol RP
Eur J Public Health; 2007 Apr; 17(2):178-85. PubMed ID: 16837520
[TBL] [Abstract][Full Text] [Related]
18. English proficiency and physicians' recommendation of Pap smears among Hispanics.
De Alba I; Sweningson JM
Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
[TBL] [Abstract][Full Text] [Related]
19. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study.
Chen LS; Huang N; Tsay JH; Wang PJ; Chou YJ; Chou P; Lee CH
Prev Med; 2007 Jun; 44(6):531-5. PubMed ID: 17467786
[TBL] [Abstract][Full Text] [Related]
20. The danger of only using a Pap smear.
Vazquez E
Posit Aware; 1999; 10(3):23. PubMed ID: 11366762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
